Gilead issues a voluntary recall of one lot of VistideĀ® (CIDOFOVIR INJECTION)
date:Feb 16, 2013
intravenous injection of product with particulate matter can vary depending on the amount of particulate matter injected into the patient, the size of the particles and the patients underlying medical condition, and can be severe. Gilead is not currently aware of any complaint attributable to the particles.

Vistide is indicated for the treatment of cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Vistide is a sterile, hypertonic aqueous solution for i
2/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/05 16:45